Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lundbeck discloses new antidepressants

Jan. 25, 2021

Hyper-IL-6 gene therapy stimulates axon regeneration and functional recovery after SCI in mice

Jan. 25, 2021

Aging immune cell energy "hoarders" play role in brain decline

Jan. 22, 2021

UCB describes new dopamine D1 receptor PAMs

Jan. 22, 2021

INmune Bio reports biomarker data from phase Ib study of XPro-1595 in Alzheimer's

Jan. 22, 2021

Tau end run prevents memory deficits, but not inflammation

Jan. 22, 2021

PK and PD data presented for ADAIR, an IR formulation of dextroamphetamine

Jan. 21, 2021

FDA approves IND for phase IIa study of JNJ-40411813 in epilepsy

Jan. 21, 2021

Big picture look reveals RNA-binding proteins' role in psychiatric disorders

Jan. 21, 2021

Long-term phase III data for lisdexamfetamine dimesylate in preschool-aged children with ADHD

Jan. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...